QCH Report FINAL V2 - Flipbook - Page 33
Queenscourt Hospice (Registered company number 2102320)
Notes to the Financial Statements
For the year ended 31 March 2024
CHARITY
Medical
Nursing
Therapists
Catering
Housekeeping
Fundraising & Administration
Education
Maintenance
Full time
3
31
3
1
1
8
4
2
Part time
4
39
2
5
5
30
5
-
Bank
8
1
1
-
Total 2024
7
78
5
6
6
39
10
2
Total 2023
8
74
4
5
6
38
9
1
53
90
10
153
145
Staff numbers exclude 14 (2023: 14) Council members, who are all non-executive Directors of the
organisation.
The number of employees whose employee benefits (excluding employer pension costs) exceeded
£60,000 was:
£60,000 - £70,000
£70,001 - £80,000
£80,001 - £90,000
£90,001 - £100,000
£100,001 - £110,000
£110,001 - £120,000
£120,001 - £130,000
£130,001 - £140,000
2024
2023
11
1
2
1
2
1
1
1
1
2
1
1
The key management personnel comprise of the 3 Executive Directors being the Medical Director, the
Director of Nursing Services and the Corporate Services Director with total employee benefit costs of
£216,280 (2023: £187,306).
In addition, a great amount of time, the value of which is impossible to reflect in these financial
statements, is donated by volunteers.
Along with a standard defined contribution scheme, the company operates an exempt approved defined
benefit scheme, namely the National Health Superannuation Scheme. The assets of this scheme are
held separately and contributions to the scheme are charged to the statement of financial activities so
as to spread the cost of pensions over employees’ working lives with the company. This scheme does
not have a real pension fund, but as a statutory scheme, benefits are fully guaranteed by the
Government. Contributions from both members and employers are paid to the Exchequer, which meet
the cost of increasing benefits each year by the rate of inflation. This extra cost is not met by
contributions from scheme members and employers, As a result of the nature of the scheme there are
no separately identifiable assets and liabilities which can be identified as relating to Queenscourt
Hospice therefore, as permitted by FRS102, the scheme has been accounted for as a defined
contribution scheme.
The contributions to the superannuation scheme were substantially defrayed by the Integrated Care
Boards (formerly Clinical Commissioning Groups).
P a g e | 33
